ConnecticutHB 054852025 Regular SessionHouse

AN ACT ESTABLISHING A CAPTIVE INSURANCE COMPANY TO ADMINISTER A BULK PURCHASE AND DISTRIBUTION OF GLUCAGON-LIKE PEPTIDE-1 PRESCRIPTION DRUGS TO QUALIFYING INDIVIDUALS IN THIS STATE TO TREAT OBESITY.

Sponsored By: Geoff Luxenberg (Democratic)

Failed

Summary

To establish a captive insurance company, which shall be supported by the appropriation of the sum of ten million dollars to said captive insurance company, from the General Fund, for the fiscal year ending June 30, 2026, for the purpose of (1) bulk purchasing glucagon-like peptide-1 receptor antagonist prescription drugs from drug manufacturers, and (2) distributing such prescription drugs to covered persons in this state who satisfy a means-tested qualification process and demonstrate an inability to obtain such prescription drugs from such covered person's health insurer to treat obesity.

insurance and real estate

Personalized for You

How does this bill affect your finances?

Personalize government policy and PRIA will tell you what this bill means for your household, plus every other piece of legislation we track. PRIA reads each provision against your financial profile to show you exactly what matters to your wallet.

Bill Overview

No Economic Impacts Identified for this Bill

Sponsors & Cosponsors

Sponsor

  • Geoff Luxenberg

    Democratic • House

Cosponsors

There are no cosponsors for this bill.

Roll Call Votes

No roll call votes available for this bill.

Actions Timeline

  1. Referred to Joint Committee on Insurance and Real Estate

    1/17/2025legislature

Bill Text

  • Proposed Bill

    1/17/2025

Related Bills

Back to State Legislation